21 November 2017
News and Views
Links and Services
The most recent issue of the Journal of Gastroenterology & Hepatology assesses the effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
Non-alcoholic fatty liver disease associated with insulin resistance is the most common cause of
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors